| In millions, except per share items | Dec-31-14 | Dec-31-13 | Dec-31-12 | Dec-31-11 | Dec-31-10 | Dec-31-09 | Dec-31-08 | Dec-31-07 |
| | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K/A |
| Interest income: |
| Interest income on loans | 31.5 | 26.1 | 31.3 | 37.5 | 49.1 | 57.8 | 69.8 | 77.3 |
| Interest income on investments | 4.4 | 5.4 | 4.5 | 4.7 | 5.3 | 6.2 | | |
| | 35.9 | 31.9 | 36.3 | 42.8 | 54.9 | 64.0 | 76.1 | 83.5 |
| Total interest expense | 5.0 | 8.5 | 12.7 | 15.0 | 20.2 | 21.8 | 30.9 | 34.6 |
| Net interest income | 30.9 | 23.4 | 23.6 | 27.8 | 34.7 | 42.2 | 45.2 | 48.9 |
| Provision for loan losses | -1.5 | -2.7 | 20.9 | 10.9 | 33.6 | 25.4 | | |
| Net interest income after provision for loan losses | 32.4 | 26.1 | 2.7 | 16.9 | 1.1 | 16.8 | 45.2 | 48.9 |
| Deposit and loan fees | 3.1 | 3.1 | 3.0 | 3.1 | 3.9 | 4.6 | 5.3 | 5.2 |
| Credit and debit card fees | 1.7 | 1.6 | 1.5 | 1.5 | 1.3 | | | |
| Gain on sale of investments, net | 0.6 | 0.3 | 0.2 | | 0.1 | | | |
| Other non-interest income | 22.8 | 15.6 | 14.6 | 14.8 | 16.8 | 5.7 | 30.2 | |
| Total non-interest income | 28.2 | 20.6 | 19.4 | 19.4 | 22.1 | 10.3 | 35.5 | 35.2 |
| Non-interest expenses | 41.7 | 47.8 | 47.7 | 47.6 | 45.3 | 68.9 | 40.4 | 41.4 |
| Asset impairment | | | | | | 27.2 | | |
| Pre-tax income | 2.9 | -13.0 | -36.8 | -22.7 | -34.7 | -41.7 | 0.8 | 16.6 |
| Income taxes | 0.5 | 0.5 | 0.8 | 0.4 | 9.7 | -8.3 | -0.6 | 5.3 |
| Tax rate | 17.9% | | | | | 19.8% | | 31.7% |
| Net income | 2.4 | 11.3 | -39.6 | -25.1 | -46.4 | -35.4 | 1.4 | 11.4 |
| Net margin | 4.0% | 24.3% | -179.6% | -69.2% | -200.1% | -130.4% | 0.5% | 13.5% |
| |
| Basic EPS | $0.04 | $0.24 | ($24.58) | ($15.79) | ($29.46) | ($22.77) | $0.08 | $0.67 |
| Diluted EPS | $0.04 | $0.24 | ($24.58) | ($15.79) | ($29.46) | ($22.77) | $0.08 | $0.66 |
| |
| Shares outstanding (basic) | 65.8 | 46.5 | 1.6 | 1.6 | 1.6 | 1.6 | 17.0 | 16.9 |
| Shares outstanding (diluted) | 65.8 | 46.5 | 1.6 | 1.6 | 1.6 | 1.6 | 17.0 | 17.2 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |